NCT06554353 Cardiopulmonary Exercise Testing and Oscillometry for the Evaluation of Dyspnea
| NCT ID | NCT06554353 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Rochester |
| Condition | Breathing, Mouth |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-10-29 |
| Primary Completion | 2026-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2024-10-29 with a primary completion date of 2026-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will determine if airway resistance to airflow and pressure, measured by Oscillometry, is associated with abnormal findings on Cardiopulmonary Exercise Testing in subjects who are experiencing shortness of breath.
Eligibility Criteria
Inclusion Criteria: * Willingness to perform breathing test * Must be able to speak and understand English * Referred for Cardiopulmonary Exercise Testing Exclusion Criteria: * Unable to provide consent or perform oscillometry test
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06554353 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Breathing, Mouth. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06554353 currently recruiting?
Yes, NCT06554353 is actively recruiting participants. Contact the research team at patrick_donohue@urmc.rochester.edu for enrollment information.
Where is the NCT06554353 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT06554353 clinical trial?
NCT06554353 is sponsored by University of Rochester. The trial plans to enroll 50 participants.